ENIGMA Brain Morphometry in CHR-P-Risk Enrichment and Antipsychotics-Reply
- PMID: 38353974
- PMCID: PMC11984043
- DOI: 10.1001/jamapsychiatry.2023.5614
ENIGMA Brain Morphometry in CHR-P-Risk Enrichment and Antipsychotics-Reply
Conflict of interest statement
Comment on
-
ENIGMA Brain Morphometry in CHR-P-Risk Enrichment and Antipsychotics.JAMA Psychiatry. 2024 Apr 1;81(4):427-428. doi: 10.1001/jamapsychiatry.2023.5611. JAMA Psychiatry. 2024. PMID: 38353961 No abstract available.
References
-
- ENIGMA. ENIGMA-Clinical High Risk Working Group home page. Accessed December 7, 2023. https://enigma.ini.usc.edu/ongoing/enigma-clinical-high-risk/
-
- CentileBrain. Home page. Accessed December 7, 2023. https://centilebrain.org/
-
- Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703–715. doi:10.1093/oxfordjournals.schbul.a007040 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
